Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (5610)	2/2/2002 1:52:16 AM
From: keokalani'nui	Read Replies (1) \| Respond to of 52153

Thank you for asking! Of those you mention, I own some kosn maxy lsbc and rigl. I recently finished buying positions in kosn and rigl, and they are the only two just mentioned that I intend to hold on to for a while. I would like to understand sangamo better. I know nothing about durect genecor cepheid and virologic. And I would not be buying the home team zymo. It is a good rule of thumb to wait at least a year after a BT IPO and be sure to enter below the IPO price, which after a year is usually not hard to do. Thus, this is a good time to scoop up the best of the class of 2000/2001. But there are much better investors around these parts with deeper understanding than me. Hope to hear from them too. Wilder